Condensed Consolidated Statements of Stockholders' Equity and Accumulated Other Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive loss
Balance beginning (in shares) at Dec. 31, 2021		141,301,569
Balance beginning at Dec. 31, 2021	$ 303,510	$ 16	$ 361,542	$ (56,797)	$ (1,251)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		944,716
Common stock issued upon exercise of stock options	268	$ (2)	270
Vested common stock awards (in shares)		132,649
Stock-based compensation	3,041		3,041
Net income (loss)	54,277			54,277
Other Comprehensive (loss) income	(10,188)				(10,188)
Ending balance at Jun. 30, 2022	350,908	$ 14	364,853	(2,520)	(11,439)
Ending balance (in shares) at Jun. 30, 2022		142,378,934
Balance beginning (in shares) at Mar. 31, 2022		141,418,989
Balance beginning at Mar. 31, 2022	308,394	$ 16	362,770	(49,451)	(4,941)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		827,296
Common stock issued upon exercise of stock options	234	$ (2)	236
Vested common stock awards (in shares)		132,649
Stock-based compensation	1,847		1,847
Net income (loss)	46,931			46,931
Other Comprehensive (loss) income	(6,498)				(6,498)
Ending balance at Jun. 30, 2022	350,908	$ 14	364,853	(2,520)	(11,439)
Ending balance (in shares) at Jun. 30, 2022		142,378,934
Balance beginning (in shares) at Dec. 31, 2022		143,034,225
Balance beginning at Dec. 31, 2022	376,905	$ 14	371,072	21,772	(15,953)
Ending balance at Mar. 31, 2023	391,142	$ 14	374,010	31,541	(14,423)
Ending balance (in shares) at Mar. 31, 2023		143,267,991
Balance beginning (in shares) at Dec. 31, 2022		143,034,225
Balance beginning at Dec. 31, 2022	376,905	$ 14	371,072	21,772	(15,953)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		371,903
Common stock issued upon exercise of stock options	54		54
Vested common stock awards (in shares)		92,596
Stock-based compensation	5,933		5,933
Net income (loss)	3,305			3,305
Other Comprehensive (loss) income	6,306				6,306
Ending balance at Jun. 30, 2023	392,503	$ 14	377,059	25,077	(9,647)
Ending balance (in shares) at Jun. 30, 2023		143,498,724
Balance beginning (in shares) at Mar. 31, 2023		143,267,991
Balance beginning at Mar. 31, 2023	391,142	$ 14	374,010	31,541	(14,423)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		208,807
Common stock issued upon exercise of stock options	31		31
Vested common stock awards (in shares)		21,926
Stock-based compensation	3,018		3,018
Net income (loss)	(6,464)			(6,464)
Other Comprehensive (loss) income	4,776				4,776
Ending balance at Jun. 30, 2023	$ 392,503	$ 14	$ 377,059	$ 25,077	$ (9,647)
Ending balance (in shares) at Jun. 30, 2023		143,498,724